InsiderClue
Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Gary M Pfeiffer
26 Oct 2026
Director
Sold on a plan
1,203
$243.00
$292.33K
J. E. Davis
1 Sep 2026
CEO and President
Sold on a plan
10,000
$242.72
$2.43M
Mark E Delaney
28 Jul 2026
SVP & Chief Commercial Officer
Sold on a plan
1,600
$235.18
$376.29K
J. E. Davis
1 Jun 2026
CEO and President
Sold on a plan
10,000
$194.14
$1.94M
Patrick Plewman
5 Mar 2026
SVP for Diagnostic Services
Sold on a plan
2,855
$206.21
$588.73K
Michael E Prevoznik
5 Mar 2026
SVP & General Counsel
Sold on a plan
3,878
$206.21
$799.68K
Catherine T. Doherty
5 Mar 2026
EVP, Regional Businesses
Sold on a plan
5,558
$206.21
$1.15M
Patrick Plewman
3 Mar 2026
SVP for Diagnostic Services
Sold on a plan
410
$207.73
$85.17K
Michael E Prevoznik
3 Mar 2026
SVP & General Counsel
Sold on a plan
526
$207.73
$109.27K
Catherine T. Doherty
3 Mar 2026
EVP, Regional Businesses
Sold on a plan
632
$207.73
$131.29K
J. E. Davis
2 Mar 2026
CEO and President
Sold on a plan
10,000
$212.52
$2.13M
Catherine T. Doherty
19 Feb 2026
EVP, Regional Businesses
Sold on a plan
1,433
$204.83
$293.52K
Michael E Prevoznik
19 Feb 2026
SVP & General Counsel
Sold on a plan
1,111
$204.83
$227.57K
Patrick Plewman
19 Feb 2026
SVP for Diagnostic Services
Sold on a plan
958
$204.83
$196.23K
Show all 37 transactions →

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 21
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 369,619
History held since 3 Oct 2006